Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Akero Therapeutics, Inc. Director's Dealing 2021

Jun 4, 2021

31200_dirs_2021-06-03_ca32d592-cda3-45a9-ba13-cd5914801f98.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akero Therapeutics, Inc. (AKRO)
CIK: 0001744659
Period of Report: 2021-06-01

Reporting Person: Bitterman Kevin (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-01 Common Stock S 16544 $26.28 Disposed 0 Indirect
2021-06-01 Common Stock S 945 $26.28 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1963529 Indirect
Common Stock 268722 Indirect

Footnotes

F1: Shares were sold pursuant to a Rule 10b5-1 trading plan.

F2: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund XI, L.P. ("AVF XI") and Atlas Venture Opportunity Fund I, L.P. ("AVOF") for no additional consideration to their respective limited and general partners, including Atlas Venture Associates XI, LP ("AVA XI LP") and Atlas Venture Associates Opportunity I, LLC ("AVAO LP"). As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.73 to
$26.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in
this footnote.

F4: These shares are owned directly by AVA XI LP. Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any.

F5: These shares are owned directly by AVAO LP. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any.

F6: These shares are owned directly by AVF XI. AVA XI LP is the general partner of AVF XI. AVA XI LLC is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of the securities held by AVF XI, except to the extent of his pecuniary interest therein, if any.

F7: These shares are owned directly by AVOF. AVAO LP is the general partner of AVOF. AVAO LLC is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of the securities held by AVOF, except to the extent of his pecuniary interest therein, if any.